Company Monitoring Page for Pfizer

latest headlines for company on cafepharma

How Bristol-Myers and Pfizer are using real-world data to unseat warfarin
Biopharma Dive
Mon, 01/29/18 - 11:59 pm
Tags:
Bristol-Myers Squibb, Pfizer, Warfarin, real world evidence, RWE, bloodthinners, Eliquis
Pfizer's Q4 Earnings Preview: Watching Ibrance And Prevnar Sales
Forbes
Fri, 01/26/18 - 05:27 pm
Tags:
Pfizer, earnings, Ibrance, Prevnar
Pfizer’s latest copycat could put the squeeze on Roche — again
Endpoints
Fri, 01/26/18 - 10:57 am
Tags:
Pfizer, Roche, biosimilars, Rituxan, PF-05280586
Pfizer's EpiPen woes creep into Canada
Biopharma Dive
Fri, 01/26/18 - 09:04 am
Tags:
Pfizer, Mylan Labs, EpiPens, Canada, drug shortages
Johnson & Johnson drops out of the race for Pfizer consumer unit, paving the way for GSK, Reckitt
Fierce Pharma
Thu, 01/25/18 - 05:29 pm
Tags:
JNJ, Pfizer, consumer health, M&A, GSK, Reckitt Benckiser
Bristol-Myers calls on real-world evidence to unseat warfarin
Biopharma Dive
Wed, 01/24/18 - 08:15 pm
Tags:
Bristol-Myers Squibb, Warfarin, Eliquis, Pfizer, bloodthinners
J&J’s move to cut Remicade price cost some big bucks, but guarded against Pfizer’s copycat
Endpoints
Tue, 01/23/18 - 09:00 pm
Tags:
JNJ, Remicade, drug pricing, Pfizer, biosimilars
Pfizer (PFE) Set to Announce Earnings on Monday
True Blue Tribune, FL
Mon, 01/22/18 - 05:43 pm
Tags:
Pfizer, earnings
GSK, Pfizer lead in new global Twitter pharma influencer ranking
Fierce Pharma
Mon, 01/22/18 - 11:01 am
Tags:
GSK, Pfizer, twitter, social media
Whom Will Pfizer Buy in 2018?
Motley Fool
Mon, 01/22/18 - 09:42 am
Tags:
Pfizer, M&A, Biogen, Bristol-Myers Squibb, Allergan
5 Highest-Growth Drugs of 2018 -- and Who Will Get Rich from Them
Motley Fool
Sun, 01/21/18 - 10:53 am
Tags:
Merck, Keytruda, AbbVie, Humira, Mavyret, Bristol-Myers Squibb, Eliquis, Pfizer, Ibrance
Beefing up its CAR-T pipeline, Gilead teams up with Pfizer on a lymphoma combo
Endpoints
Thu, 01/18/18 - 10:06 am
Tags:
CAR-T, Gilead Sciences, Pfizer, utomilumab, Yescarta, large B-cell lymphoma
With Pfizer in hot pursuit, J&J loses a critical patent fight as it scrambles for a new prostate cancer drug OK
Endpoints
Thu, 01/18/18 - 10:00 am
Tags:
Pfizer, JNJ, patents, Zytiga, Xtandi, prostate cancer, apalutamide
Pay-raise rant gone bad at Pfizer underscores worker angst
Oregon Live
Tue, 01/16/18 - 09:59 am
Tags:
Pfizer, Ian Read, Pharma CEOs
After 5 years, Eliquis' growth ceiling is nowhere in sight: Bristol-Myers CEO
Fierce Pharma
Thu, 01/11/18 - 09:48 am
Tags:
Bristol-Myers Squibb, Eliquis, Pharma CEOs, Giovanni Caforio, Pfizer, JPMHC 2018
JPM18: GSK's Walmsley weighs in on Pfizer, gender diversity
Biopharma Dive
Wed, 01/10/18 - 06:53 pm
Tags:
GSK, Emma Walmsley, Pfizer, Pharma CEOs, gender diversity, JPMHC 2018
The 1 Word That Explains Why Pfizer's Future Looks Brighter Than Its Past
Motley Fool
Tue, 01/9/18 - 10:17 am
Tags:
Pfizer, JPMHC 2018, productivity
Pfizer is axing its neurosciences division, laying off 300 and discarding new drugs
Endpoints
Sun, 01/7/18 - 12:50 pm
Tags:
Pfizer, R&D, layoffs, Neurosciences
In surprise move, Pfizer hands back IDO1 inhibitor
Biopharma Dive
Sat, 01/6/18 - 12:29 pm
Tags:
Pfizer, IDO1, iTeos Therapeutics, EOS200271, glioma
Pfizer, Novartis and more post price hikes on dozens of drugs, but AbbVie’s is worth the most
Fierce Pharma
Thu, 01/4/18 - 10:27 pm
Tags:
drug pricing, Pfizer, Novartis, AbbVie

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.